Determination That REVIA (Naltrexone Hydrochloride) Tablets, 50 Milligrams Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that REVIA (naltrexone hydrochloride) tablets, 50 milligrams (mg), was not withdrawn from sale for reasons of safety or effectiveness....
Sign up to read the full analysisDocument type: Notice. Agency: Health and Human Services Department, Food and Drug Administration. Published: 2026-04-16.
Why this matters to food and beverage teams
This notice is worth screening if your team tracks health and human services department, food and drug administration activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.
Federal Register items are often early signals. Even when they look procedural, they can affect comment windows, effective dates, or how suppliers and plants plan around upcoming changes.
Track this document and its deadlines
Get the full analysis, comment period alerts, and compliance calendar -- free for F&B professionals.
Sign Up Free